Veradermics MANE
NYSE MANE
$149.42 +5.47 (+3.80%)
As of: Nov 10, 2026 · 2:54 PM EST

Veradermics (MANE) Retained Earnings (2024 - 2026)

Updated

Veradermics (MANE) posted Retained Earnings of -$174.2 million for Q2 2026.

Analysis

Veradermics (MANE) Retained Earnings (2024 - 2026) Analysis & Trends

At the end of FY2025, Veradermics' Retained Earnings came in at -$123.42 million.

  • In prior years, Veradermics' Retained Earnings was -$49.23 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 37.97 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 168.36 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -16.19 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 66.22 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 12.59 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -19.81 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 3.11 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 115.33 Bn
10 Veradermics 6.01 Bn 4.61 Bn - -174.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -174.20 Mn
Mar 31, 2026 -150.70 Mn
Dec 31, 2025 -123.42 Mn
Dec 31, 2024 -49.23 Mn
API Access

Veradermics Retained Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=retained-earnings&ticker=MANE&period=max&api_key=YOUR_API_KEY